The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole sulfate ID: ALA2074805
Cas Number: 157192-07-9
PubChem CID: 443293
Max Phase: Preclinical
Molecular Formula: C16H17N3O4S2
Molecular Weight: 379.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNc1nc2c(Cc3cccnc3)c(C)c(OS(=O)(=O)O)c(C)c2s1
Standard InChI: InChI=1S/C16H17N3O4S2/c1-9-12(7-11-5-4-6-18-8-11)13-15(24-16(17-3)19-13)10(2)14(9)23-25(20,21)22/h4-6,8H,7H2,1-3H3,(H,17,19)(H,20,21,22)
Standard InChI Key: LPZDTQCWCMPFND-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.7845 -1.5229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6411 -1.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1435 -1.3654 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.6284 -0.6979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1435 -0.0305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6411 -0.2854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3556 0.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0701 -0.2854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0701 -1.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3556 -1.5229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3556 0.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0734 2.6021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6411 2.1896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6411 1.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0734 0.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7878 1.3646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7878 2.1896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4534 -0.6979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8659 0.0165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7845 0.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3556 -2.3479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4990 -1.1104 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.2135 -1.5229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9156 -0.5271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0824 -0.5271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
2 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
2 10 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
12 17 1 0
11 14 1 0
7 11 1 0
18 19 1 0
4 18 1 0
8 20 1 0
10 21 1 0
1 9 1 0
1 22 1 0
22 23 1 0
22 24 2 0
22 25 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: YesOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.46Molecular Weight (Monoisotopic): 379.0660AlogP: 3.12#Rotatable Bonds: 5Polar Surface Area: 101.41Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: -2.00CX Basic pKa: 5.47CX LogP: 1.04CX LogD: 1.02Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.66Np Likeness Score: -0.49
References 1. Suzuki M, Suzuki H, Sugimoto Y, Sugiyama Y.. (2003) ABCG2 transports sulfated conjugates of steroids and xenobiotics., 278 (1): [PMID:12682043 ] [10.1074/jbc.m212399200 ] 2. Kouzuki H, Suzuki H, Ito K, Ohashi R, Sugiyama Y.. (1999) Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes., 288 (1): [PMID:9918568 ]